EXPLORING THE INCIDENCE OF OTOMYCOSIS IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED INDIVIDUALS

RVM SRI HARSHA; DESU VYSHNAVI; KOPPADA SOWMYA

doi:10.22159/ijcpr.2025v17i5.7051

Authors

RVM SRI HARSHA CMR Institute of Medical Sciences, Hyderabad, Telangana, India
DESU VYSHNAVI Senior Resident, CMR Institute of Medical Sciences, Hyderabad and Telangana, India
KOPPADA SOWMYA CMR Institute of Medical Sciences, Hyderabad, Telangana, India

DOI:

https://doi.org/10.22159/ijcpr.2025v17i5.7051

Keywords:

Otitis externa, Otomycosis, Diabetes mellitus, HIV/AIDS

Abstract

Objective: This study aims to evaluate the incidence, clinical presentation, mycological profile, and treatment outcomes of otomycosis in immunocompetent versus immunocompromised individuals.

Methods: This prospective cohort study was conducted over one year and included 300 randomly selected patients with ear complaints, divided equally into immunocompetent and immunocompromised groups. Diagnosis was confirmed via KOH mount and culture on Sabouraud’s Dextrose Agar. Treatment involved aural toileting and topical antifungal therapy, starting with Clotrimazole and escalating to Fluconazole if needed.

Results: Otomycosis was diagnosed in 101 patients: 26% in the immunocompetent group and 41.3% in the immunocompromised group, showing statistical significance (p=0.0070). Males were more affected in both groups. Aspergillus Niger was most common in immunocompetent, while Candida species dominated in immunocompromised patients. Recovery time was shorter in immunocompetent patients (10±3.5 d) compared to immunocompromised ones (16±4.2 d), with 35.4% requiring Fluconazole.

Conclusion: Otomycosis is more prevalent and tougher to manage in immunocompromised individuals, with Candida species as the leading pathogen. Tailored treatment, including timely escalation from Clotrimazoleto Fluconazole, is essential in these patients.

Downloads

Download data is not yet available.

References

1. Carney AS. Otitis externa and otomycosis. In: Gleeson MJ, Browning G, editors. G. Burton MJ, Clarke R, Hibbert J, Jones NS, Lund VJ, Luxon LM, Watkison JC. Scott-Brown’s Otolaryngology, Head and Neck Surgery. Vol. 3. 7th ed. London: Hodder Arnold Publishers; 2008. p. 3351-7.

2. Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. Ear Nose Throat J. 2008;87(11):622-3. doi: 10.1177/014556130808701107, PMID 19006061.

3. Wolf FT. Relation of various fungi to otomycosis. Arch Otolaryngol (1925). 1947;46(3):361-74. doi: 10.1001/archotol.1947.00690020372009, PMID 20265711.

4. Than KM, Naing KS, Min M. Otomycosis in Burma and its treatment. Am J Trop Med Hyg. 1980;29(4):620-3. doi: 10.4269/ajtmh.1980.29.620, PMID 6447461.

5. Yassin A, Maher A, Moawad MK. Otomycosis: a survey in the eastern province of Saudi Arabia. J Laryngol Otol. 1978;92(10):869-76. doi: 10.1017/s0022215100086242, PMID 712219.

6. Chandler JR. Malignant external otitis. Laryngoscope. 1968;78(8):1257-94. doi: 10.1288/00005537-196808000-00002, PMID 4970362.

7. Paulose KO, Al KS, Shenoy P, Sharma RK. Mycotic infection of the ear (Otomycosis) a prospective study. JLO. 1989 Jan;103(1):30-5. doi: 10.1017/s0022215100107960.

8. Viswanatha B, Sumatha D, Vijayashree MS. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review. Ear Nose Throat J. 2012 Mar;91(3):114-21. doi: 10.1177/014556131209100308, PMID 22430336.

9. Bojanovic M, Stalevic M, Arsic Arsenijevic V, Ignjatovic A, Randelovic M, Golubovic M. Etiology, predisposing factors clinical features and diagnostic procedure of otomycosis: a literature review. J Fungi (Basel). 2023 Jun 13;9(6):662. doi: 10.3390/jof9060662, PMID 37367598.

10. Swain SK, Behera IC, Sahu MC, Das A. Povidone iodine soaked gelfoam for the treatment of recalcitrant otomycosis our experiences at a tertiary care teaching hospital of eastern India. J Mycol Med. 2018 Mar;28(1):122-7. doi: 10.1016/j.mycmed.2017.11.006, PMID 29223643.

11. Anwar K, Gohar MS. Otomycosis; clinical features predisposing factors and treatment implications. Pak J Med Sci. 2014 May;30(3):564-7. doi: 10.12669/pjms.303.4106, PMID 24948980.